Overall rank by patents
#35,259
of 49,997 tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 1 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G10H (Electrophonic Musical INSTRUMENTS; Instruments IN Which THE Tones ARE Generated BY Electromechanical Means OR Electronic Generators, OR IN Which THE Tones ARE Synthesised From A Data Store).
The verdict
According to USPTO PatentsView, Exomens ranks #35,259 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 1 technology areas.
USPTO PatentsView assignee plate
Corpus R35259 · Foreign Corporation #35,259 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Evestra, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Exomens · this assignee
20 score
3D Lighting… · lowest
7 score
What this shows Exomens's Innovation Score is 20.1/100 (6th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Exomens is a focused PatentsView assignee: 1 CPC subclasses with 100% of grants classified under G10H (Electrophonic Musical INSTRUMENTS; Instruments IN Which THE Tones ARE Generated BY Electromechanical Means OR Electronic Generators, OR IN Which THE Tones ARE Synthesised From A Data Store). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2017. By volume, Exomens sits between Evestra, Inc. and Extrude to Fill, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Evestra, Inc.
7 patents
Evolva, Inc.
7 patents
Evolve Dental Technologies, Inc.
7 patents
Exmar Offshore Company
7 patents
Expose Retail Strategies, Inc.
7 patents
ExteNet Systems, Inc.
7 patents
Extract Management Company, LLC
7 patents
Extrude to Fill, Inc.
7 patents
Exomens
7 patents
What this shows Exomens holds 7 patents at rank #35,253, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #35,253 in granted patent volume.
Other assignees with the most granted patents in Exomens's primary technology class.
Exomens's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
20 6th percentile higher than 6% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 71.4% |
| 2017 | 1 | 14.3% |
| 2018 | 1 | 14.3% |
Top 1 of 1 technology areas
Overall rank by patents
#35,259
of 49,997 tracked assignees
20.1 out of 100
What to do with this data
Exomens's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.